Pharmacotherapy: Non-serotonergic mechanisms

Gut

Volumn 51, Issue SUPPL. 1, 2002, Pages

  Spiller, Robin ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; CLONIDINE; EZLOPITANT; FEDOTOZINE; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; LIDAMIDINE; LOPERAMIDE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NORADRENALIN UPTAKE INHIBITOR; OCTREOTIDE; OPIATE; OXYTOCIN; SEROTONIN UPTAKE INHIBITOR; SOMATOSTATIN; TACHYKININ RECEPTOR ANTAGONIST; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIC ACTIVITY; ANTINOCICEPTION; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; IRRITABLE COLON; NEUROMODULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VISCERAL PAIN;

EID: 0036288597     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.suppl_1.i87     Document Type: Conference Paper

References (53)

1. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients
2. Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
3. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception
4. Local analgesic effect of endogenous opioid peptides
5. The control of pain in peripheral tissue by opioids
6. Placebo and naroxone can alter post-surgical pain by separate mechanisms
7. Is placebo analgesia mediated by endogenous opioids? A systematic review
8. Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: Activation of descending inhibition by morphine, glutamate and electrical stimulation
9. Quantitative comparison of inhibition of visceral and cutaneous spinal nociceptive transmission from the midbrain and medulla in the rat
10. Rectal afferent function in patients with inflammatory and functional intestinal disorders
11. Iritable bowel syndrome patients show altered sensitivily to exogenous opioids
12. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea
13. Role of loperamide and placebo in management of irritable bowel syndrome (IBS)
14. Loperamide in treatment of irritable bowel syndrome - A double-blind placebo controlled study
15. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and withoul acute colonic inflammation
16. Fedotozine blocks hypersensitive visceral pain in conscious rats: Action at peripheral kappa-opioid receptors
17. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome: A multicenter dose-response study
18. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn
19. Spinal somatostatin superfusion in viva affects activity of cat nociceptive dorsal horn neurons: Comparison with spinal morphine
20. Intrathecal somatostatin in terminally ill patients. A report of two cases
21. The effect of epidural somatostatin on postoperative pain
22. Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivily in chronic pain patients
23. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention
24. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition
25. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients
26. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone
27. The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor
28. Postprandial plasma 5-hydroxytryptamine in diarrhaea predominant irritable bowel syndrome: A pilot study
29. Somatostatin and symptomatic relief of irritable bowel syndrome
30. Inhibitory control of proximal colonic motilily by the sympathetic nervous system
31. Differential effects of morphine and clonidine on visceral and cutaneous spinal nociceptive transmission in the rat
32. Postoperative analgesia with extradural clonidine
33. Low-dose clonidine infusion during labour
34. Intra-articular clonidine analgesia after knee arthroscopy
35. Adrenergic modulation of human colonic motor and sensory function
36. Effect of lidamidine, a proposed alpha 2-adrenoreceptor agonist, on salt and water transport in human jejunum
37. Cronidine prolongs human small intestine transit time: Use of the lactulose-breath hydrogen test
38. Effect of clonidine on oro-cecal transit time in normal man
39. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics
40. A multicenter doubre-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhaea
41. Double-blind study of an alpha 2 agonist in the treatment of irritable bowel syndrome
42. 2-adrenergic agonist on gastrointestinal transit, colonic motilily and sensation in humans
43. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis
44. Effects af desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
45. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans
46. Amitriptyline for the treatment of IBS
47. Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations
48. A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients
49. Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats
50. Vasopressin analgesia: Specificity of action and non-opioid effects
51. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: Analgesic effect in a patient with intractable cancer pain
52. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome
53. Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical study